Advertisement

Association of eNOS and ACE gene polymorphisms as a genetic risk factor in gestational diabetes in Iranian women

  • Mani Mirfeizi
  • Mandana Hasanzad
  • Mahshid Sattari
  • Mahdi Afshari
  • Davood Abbasi
  • Zarin Ajoodani
  • Ali Bani Sheykheslam
Research Article
  • 5 Downloads

Abstract

Background

Gestational diabetes mellitus (GDM) is the most popular metabolic disease during pregnancy. The aim of the present study was to investigate any possible association between eNOS Glu298Asp and ACE I/D gene polymorphisms and the risk of GDM in a group of Iranian pregnant women.

Methods

In this case-control study 204 pregnant women were recruited (94 cases and 110 controls). Genomic DNA was isolated from whole blood and genotyping was performed by the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR- RFLP) and only PCR for eNOS and ACE polymorphisms respectively.

Results

Frequencies of GT and TT genotype of eNOS polymorphism among women with and without GDM were 67.90% vs. 74.47 and 7.41% vs. 8.51% respectively (P = 0.4). Corresponding figures for DD genotype of ACE polymorphism among GDM patients was more than that in healthy women (51.65% vs. 63.81% respectively). Conversely, ACE heterozygote genotype was more common in diabetic women (35.16% vs. 26.67% respectively). Although these differences were not statistically significant (P = 0.2).

Conclusions

Our study showed that there is no association between the presence of eNOS and ACE gene polymorphisms and developing gestational diabetes mellitus among pregnant women in our population. Further longitudinal and multicenter studies should be carried out to assess the exact metabolic effects of these polymorphisms.

Keywords

Gestational diabetes Polymorphism eNOS Angiotensin I converting enzyme 

Abbreviations

T2D

Type 2 Diabetes

GDM

Gestational Diabetes Mellitus

eNOS

endothelial Nitric Oxide Synthase

ACE

Angiotensin Converting Enzyme

OGCT

Oral Glucose Challenge Test

T1DM

Type 1 Diabetes Mellitus

BMI

Body Mass Index

ADA

American Diabetes Association

I/D

Insertion/Deletion.

Notes

Acknowledgments

The authors acknowledge the contribution of the subjects in this study. The authors would like to thank all gestational diabetic patients who involved in this survey. And this study was supported by Karaj Branch, Islamic Azad University, Alborz, Iran.

Authors’ contributions

MM: conceived and designed the present study and gave final approval and critically revised the manuscript; MH: designed the Genetic study; MS: technical Genetic laboratory; MA: Statistical analysis; DA: sample collection & clinical study; ZA: sample collection; ZB: sample collection; AB: sample collection.

Funding

This study was supporting by Karaj Branch, Islamic Azad University, Alborz, Iran.

Compliance with ethical standards

Competing interests

The authors declare that there is no conflict of interest.

Consent for publication

Oral and written consent were obtained from the patients.

References

  1. 1.
    Coustan DR. Gestational diabetes mellitus. Clin Chem. 2013;59(9):1310–21.CrossRefPubMedGoogle Scholar
  2. 2.
    Zhang Y, Sun C-M, Hu X-Q, Zhao Y. Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis. Sci Rep 2014;4:6113.Google Scholar
  3. 3.
    Kamana K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl. 2):14–20.Google Scholar
  4. 4.
    Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. Diabetes Res Clin Pract. 2011;91(3):353–62.CrossRefPubMedGoogle Scholar
  6. 6.
    Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res. 2007;75(2):247–60.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008;5(6):338–49.CrossRefPubMedGoogle Scholar
  8. 8.
    Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci. 2001;22(7):361–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Ziaei S, Samzadeh M, Jamaldini SH, Afshari M, Haghdoost AA, Hasanzad M. Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer. Int J Biol Markers. 2013;28(1):43–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Marsden PA, Heng H, Scherer S, Stewart R, Hall A, Shi X, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478–88.PubMedGoogle Scholar
  11. 11.
    Ezzidi I, Mtiraoui N, Mohamed MBH, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and− 786T> C gene variants with diabetic nephropathy. J Diabetes Complicat. 2008;22(5):331–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Sayed-Tabatabaei F, Oostra B, Isaacs A, Van Duijn C, Witteman J. ACE polymorphisms. Circ Res. 2006;98(9):1123–33.CrossRefPubMedGoogle Scholar
  13. 13.
    Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1)(dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20(6):1433.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51(1):197–205.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Baudin B. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic Considerations Pharmacogenomics. 2002;3(1):65–73.PubMedGoogle Scholar
  16. 16.
    Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism. 1995;44(2):267–72.CrossRefPubMedGoogle Scholar
  17. 17.
    İlhan N, Ateş K, İlhan N, Kaman D, Çeliker H. eNOS Glu298Asp polymorphism and endothelial dysfunction in patients with and without end-stage renal disease. Balkan Med J. 2016;33(2):128–37.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Martinelli NC, Santos KG, Biolo A, La Porta VL, Cohen CR, Silvello D, et al. Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: an haplotype analysis. Nitric Oxide. 2012;26(3):141–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Thameem F, Puppala S, Arar NH, Stern MP, Blangero J, Duggirala R, et al. Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans. Diab Vasc Dis Res. 2008;5(2):109–13.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Haijuan H, Fan Z, Meilin Z, Guifen C, Haiyun H, Pinff H. Relationship between endothelial nitric oxide synthase Glu298Asp gene polymorphisms and the chronic periodontitis with type 2 diabetes mellitus. Hua Xi Kou Qiang Yi Xue Za Zhi. 2012;30(6):628–31.Google Scholar
  21. 21.
    Atay AE, Akbas H, Tumer C, Sakar MN, Esen B, Incebiyik A, et al. The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes. Clin Nephrol. 2014;81(2):105–11.CrossRefPubMedGoogle Scholar
  22. 22.
    Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaghchi H, et al. The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample. Endocr J. 2003;50(4):393–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes H, Akalin A, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract. 2005;59(10):1137–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant. 2000;15(7):1008–13.CrossRefPubMedGoogle Scholar
  25. 25.
    Liyun L, Songbiao L, Chengshan W, Xiufang L. Left ventricular diastolic dysfunction and obesity: a systematic review and meta-analysis of echocardiographic studies. International Journal of Cardiovascular and Cerebrovascular Disease. 2016;4(3):27–34.Google Scholar
  26. 26.
    Dostálová Z, Bienertová-Vasků A, Vasků A, Gerychová R, Unzeitig V. Insertion-deletion polymorphism in the gene for angiotensin-converning enzyme (I/D ACE) in pregnant women with gestational diabetes. Ceska Gynekol. 2006;71(5):369–73.PubMedGoogle Scholar
  27. 27.
    Khan IA, Jahan P, Hasan Q, Rao P. Angiotensin-converting enzyme gene insertion/deletion polymorphism studies in Asian Indian pregnant women biochemically identifies gestational diabetes mellitus. J Renin-Angiotensin-Aldosterone Syst. 2014;15(4):566–71.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Mani Mirfeizi
    • 1
  • Mandana Hasanzad
    • 2
    • 3
  • Mahshid Sattari
    • 2
  • Mahdi Afshari
    • 4
  • Davood Abbasi
    • 5
  • Zarin Ajoodani
    • 1
    • 6
  • Ali Bani Sheykheslam
    • 7
  1. 1.Department of Midwifery, College of Nursing & MidwiferyIslamic Azad University, Karaj BranchAlborzIran
  2. 2.Medical Genomics Research CenterIslamic Azad University, Tehran Medical Sciences BranchTehranIran
  3. 3.Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences InstituteTehran University of Medical SciencesTehranIran
  4. 4.Department of Community MedicineZabol University of Medical SciencesZabolIran
  5. 5.Iranian Diabetes Society, Eslamshahr BranchEslamshahrIran
  6. 6.Alborz HospitalAlborzIran
  7. 7.Ghaem HospitalAlborzIran

Personalised recommendations